
Monster Reign 12/Case


Get Monster's Reign Energy Drink At Best Price Nutrition!
If you're looking for an intense fitness drink, look no further. Monster Reign is an ultimate beverage for focus, filled with 300 whopping milligrams of Caffeine, CoQ10 & Electrolytes. This drink was designed to help people with an active lifestyle to keep on going (just like the Energizer Bunny). This drink acts as both a delicious refresher & also a powerful pre-workout to help even the toughest gym junkie get through their workout. INTRODUCING (finally) MONSTER'S REIGN ENERGY DRINK!!
Enjoy an entire can of Reign whenever you need more energy. Whether it is before the gym, before school, before work or whenever you need that boost!
Serving Size: 8 fl oz
Servings Per Container: 2
Amount Per Serving
Calories 0
Total Fat 0g
Sodium 100mg
Total Carbohydrate 1g
Sugars 0g
Protein 0g
Percent Daily Values Are Based On A 2,000 Calorie Diet.
Other Ingredients: Carbonated Water, Citric Acid, Natural Flavors, Sodium Citrate, L-Leucine, Caffeine, L-Isoleucine, L-Valine, Sucralose, Potassium Sorbate (Preservative), Potassium Citrate, Sodium Benzoate (Preservative), Niacinamide (Vit B3), Magnesium Citrate, Coenzyme Q-10, Pyridoxine Hydrochloride (Vit B6), Cyanocobalamin (Vit B12).
Consume Responsibly: Not recommended for persons under 18 years old, people sensitive to caffeine, pregnant women or women who are nursing. Intended for healthy adults only. Consult a Healthcare Professional before consuming this product if your are taking any medication or if you have any preexisting medical conditions.
Cappelletti S, Piacentino D, Sani G, Aromatario M. Caffeine: cognitive and physical performance enhancer or psychoactive drug? [published correction appears in Curr Neuropharmacol. 2015;13(4):554. Daria, Piacentino [corrected to Piacentino, Daria]]. Curr Neuropharmacol. 2015;13(1):71–88. doi:10.2174/1570159X13666141210215655
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462044/
Kolahdouzan M, Hamadeh MJ. The neuroprotective effects of caffeine in neurodegenerative diseases. CNS Neurosci Ther. 2017;23(4):272–290. doi:10.1111/cns.12684